Table 2

- Univariate analysis of prognostic factors associated with unfavorable neurological outcome in the derivation cohort.

VariablesUnfavorable outcome CPC 3-5 (n=58)Favorable outcome CPC 1-2 (n=22)P-value
Age (years), mean±SD49.35±19.5352.55±17.290.502
Male, n (%)40 (69.0)14 (63.6)0.650
Witnessed, n (%)39 (67.2)21 (95.5)0.009
Bystander CPR, n (%)36 (62.1)19 (86.4)0.036
Out-of-hospital CA, n (%)35 (60.3)12 (54.5)0.638
Comorbidities, n (%)
Coronary artery disease9 (15.5)0 (0)0.118
Hypertension22 (37.9)9 (40.9)0.807
Diabetes8 (13.8)6 (27.3)0.277
Stroke6 (10.3)3 (13.6)0.984
Initial rhythm, shockable, n (%)16 (27.6)13 (59.1)0.009
Cardiac etiology, n (%)27 (46.6)14 (63.6)0.172
Duration of resuscitation (min), median (IQR)40.00 (25.75-79.75)29.50 (16.75-51.75)0.035
Length of stay in hospital (d), median (IQR)11.50 (5.00-23.25)18.50 (14.00-24.25)0.097
GCS-M ≤ 2, n (%)54 (93.1)7 (31.8)<0.001
Pupillary/corneal reflex, n (%)30 (51.7)22 (100)<0.001
GWR, median (IQR)
Basal ganglia1.15 (1.08-1.24)1.27 (1.22-1.37)<0.001
Average1.20 (1.09-1.31)1.32 (1.24-1.44)0.001
NSE (ng/ml), median (IQR)151.60 (67.23-347.35)37.00 (30.32-49.95)<0.001
  • CPC- cerebral performance category, SD- standard deviation, CPR- cardiopulmonary resuscitation, CA- cardiac arrest, IQR- interquartile range, GCS-M- Glasgow Coma Scale motor score, GWR - gray-white matter ratio, NSE - neuron-specific enolase